Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia

Bone Marrow Transplantation

Volumn 17, Issue 4, 1996, Pages 643-647

  Mackinnon, S ^a,b   Barnett, L ^a   Heller, G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

BMT; CML; PCR; Relapse; T cell depletion

Indexed keywords

BCR ABL PROTEIN; MESSENGER RNA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; CANCER GENETICS; CANCER RECURRENCE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOGENETICS; DIAGNOSTIC TEST; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE;

BONE MARROW; BONE MARROW TRANSPLANTATION; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; FUSION PROTEINS, BCR-ABL; LEUKEMIA, MYELOID, CHRONIC-PHASE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LIFE TABLES; LYMPHOCYTE DEPLETION; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029981482     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Apperley JF, Jones L, Hale G et al. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft versus host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant 1986; 1: 53-68.
2. Pichert G, Alyea EP, Soiffer RJ et al. Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Blood 1994; 84: 2109-2114.
3. Kawasaki ES, Clark SS, Coyne MY et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988; 85: 5698-5702.
4. Lange W, Snyder DS, Castro R et al. Detection by enzymatic amplification of bcr-abl mRNA in peripheral blood and bone marrow cells of patients with chronic myelogenous leukemia. Blood 1989; 73: 1735-1741.
5. Hughes TP, Morgan GJ, Martiat P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874-878.
6. Pignon JM, Henni T, Amselem S et al. Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia 1990; 4: 83-86.
7. Sawyers CL, Timson L, Kawasaki ES et al. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 563-567.
8. Morgan GJ, Hughes T, Janssen JW et al. Polymerase chain reaction for detection of residual leukaemia. Lancet 1989; 1: 928-929.
9. Gabert J, Thuret I, Lafage M et al. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone-marrow transplantation. Lancet 1989; 2: 1125-1128.
10. Martiat P, Maisin D, Philippe M et al. Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primers. Br J Haematol 1990; 75: 355-358.
11. Roth MS, Antin JH, Ash R et al. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 1992; 79: 276-282.
12. Cross NCP, Hughes TP, Feng L et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol 1993; 84: 67-74.
13. Delage R, Soiffer RJ, Dear K, Ritz J. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. Blood 1991; 78: 2759-2767.
14. Miyamura K, Tahara T, Tanimoto M et al. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. Blood 1993; 81: 1089-1093.
15. Guerrasio A, Martinelli G, Saglio G et al. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants. Leukemia 1992; 6: 507-512.
16. Lee M, Khouri I, Champlin R et al. Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation. Br J Haematol 1992; 82: 708-714.
17. Lange W, Herkert R, Finke J et al. Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation. Ann Hematol 1991; 63: 189-194.
18. Collins NH, Bleau SA, Kernan NA, O'Reilly RJ. T cell depletion of bone marrow by treatment with soybean agglutinin and sheep red blod cell rosetting. In: Areman EM, Deeg HJ, Sacher RA (eds). Bone Marrow and Stem Cell Processing: A Manual of Current Techniques. FA Davis: New York, 1992, pp 171-180.
19. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 1987; 162: 156-159.
20. Mackinnon S, Barnett L, Heller G, O'Reilly RJ. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 3409-3416.
21. Kwok S, Higushi R. Avoiding false positives with PCR. Nature 1989; 339: 237.
22. Mohamed AN, Clarkson BD, Chaganti RSK. High resolution banding of chronic myeloid leukemia chromosomes. Cancer Genet Cytogenet 1986: 20: 209-222.
23. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Wiley: New York, 1980.
24. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions following bone marrow transplantation in humans. Blood 1990; 75: 555-562.
25. Offit K, Bums JP, Cunningham I et al. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood 1990; 75: 1346-1355.
26. Lion T, Henn T, Gaiger A et al. Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet 1993; 341: 275-276.
27. Cross NCP, Feng L, Chase A et al. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929-1936.
28. Mackinnon S, Papadopoulos EP, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia following bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-1268.